Summarized by Masters of Longevity from Longevity Technology.
Engineered exosome-based therapy: a profile piece that previews a university team’s novel approach to targeting aging tissues and next steps.
Key Takeaways
- The Tohoku University team engineered lanthanide-modified exosomes that selectively home to senescent cells to deliver reparative cargo.
- In aged mice, these engineered exosomes improved frailty scores, physical performance, and multiple aging markers without apparent safety concerns.
- The team plans human clinical studies to test whether the mouse-derived effects translate into meaningful healthy-years extension.
